Response by Piccini et al to Letters Regarding Article, 'Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation'

著录项

• 来源
  《Circulation: An Official Journal of the American Heart Association》 |2016年第2期|共2页
• 作者

  Piccini Jonathan P.; Hellkamp Anne S.; Washam Jeffrey B.; Becker Richard C.; Breithardt Guenter; Berkowitz Scott D.; Halperin Jonathan L.; Hankey Graeme J.; Hacke Werner; Mahaffey Kenneth W.; Nessel Christopher C.; Singer Daniel E.; Fox Keith A. A.; Patel Manesh R.;

  展开▼
• 作者单位

  Duke Univ Med Ctr Duke Clin Res Inst Durham NC USA;

  Duke Univ Med Ctr Duke Clin Res Inst Durham NC USA;

  Duke Univ Med Ctr Duke Heart Ctr Durham NC 27710 USA;

  Univ Cincinnati Coll Med Cincinnati OH USA;

  Hosp Univ Munster Munster Germany;

  Bayer HealthCare Pharmaceut Parsippany NJ USA;

  Mt Sinai Med Ctr Zena &

  Michael A Wiener Cardiovasc Inst New York NY 10029 USA;

  Univ Western Australia Sch Med &

  Pharmacol Crawley Australia;

  Heidelberg Univ Heidelberg Germany;

  Stanford Univ Dept Med Stanford CA 94305 USA;

  Janssen Pharmaceut Res &

  Dev Raritan NJ USA;

  Massachusetts Gen Hosp Boston MA 02114 USA;

  Univ Edinburgh Edinburgh EH8 9YL Midlothian Scotland;

  Duke Univ Med Ctr Duke Clin Res Inst Durham NC USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 心脏、血管（循环系）疾病;
• 关键词